我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1914
已完成
100.0%
暂无批准数据
- Toyobo Co., Ltd. and DMC Biotechnologies have signed a multi-year collaboration agreement to develop sustainable, fermentation-produced chemical intermediates for essential materials production. - The partnership combines DMC's proprietary Dynamic Metabolic Control™ technology with Toyobo's chemical synthesis and biotechnology expertise to create cost-effective bio-based chemical products. - The collaboration aims to address biomanufacturing's challenge of higher production costs compared to conventional chemical processes while reducing greenhouse gas emissions and fossil resource dependency. - Toyobo plans to utilize the optimized microorganisms and compounds as raw materials for its films and plastic products, supporting its Sustainable Vision 2030 goal of contributing to a decarbonized society.